Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors.
Min L, Wang X, Chen A, Zhou Y, Ge Y, Dai J, Chang X, Sun W, Liu Q, Zhou X, Tian M, Kong W, Zhu J, Shen J, Liu B, Li R.
Min L, et al. Among authors: zhu j.
Future Oncol. 2024 Mar 6. doi: 10.2217/fon-2023-0962. Online ahead of print.
Future Oncol. 2024.
PMID: 38445361
Review.